| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 27.712 | 30.712 | 37.756 | 42.186 | 47.859 | 45.820 | 52.053 | 47.469 | 47.004 | 51.369 |
| Total Income - EUR | 27.713 | 30.718 | 37.759 | 42.190 | 47.862 | 45.823 | 52.057 | 47.473 | 47.009 | 51.454 |
| Total Expenses - EUR | 11.815 | 10.412 | 8.302 | 10.733 | 10.537 | 9.970 | 11.789 | 9.280 | 9.782 | 14.298 |
| Gross Profit/Loss - EUR | 15.898 | 20.306 | 29.456 | 31.456 | 37.325 | 35.853 | 40.269 | 38.193 | 37.228 | 37.156 |
| Net Profit/Loss - EUR | 15.066 | 19.691 | 28.979 | 31.034 | 36.847 | 35.567 | 39.761 | 37.728 | 36.767 | 35.644 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Orient-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 15.990 | 24.568 | 29.701 | 31.986 | 37.801 | 36.339 | 40.508 | 41.875 | 37.637 | 58.979 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1.277 | 1.286 | 1.349 | 1.536 | 3.532 | 1.527 | 1.147 | 27.917 | 4.694 | 23.357 |
| Cash | 14.712 | 23.281 | 28.352 | 30.450 | 34.268 | 34.813 | 39.361 | 13.957 | 32.943 | 35.621 |
| Shareholders Funds | 15.120 | 19.745 | 29.032 | 31.085 | 36.897 | 35.617 | 39.672 | 37.777 | 36.816 | 35.692 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 869 | 4.823 | 670 | 901 | 903 | 723 | 837 | 4.098 | 822 | 23.287 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Orient-Med Srl